Harry E Fuentes

768 total citations
48 papers, 531 citations indexed

About

Harry E Fuentes is a scholar working on Internal Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Harry E Fuentes has authored 48 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Internal Medicine, 16 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Harry E Fuentes's work include Venous Thromboembolism Diagnosis and Management (23 papers), Central Venous Catheters and Hemodialysis (7 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Harry E Fuentes is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (23 papers), Central Venous Catheters and Hemodialysis (7 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Harry E Fuentes collaborates with scholars based in United States, Spain and France. Harry E Fuentes's co-authors include Alfonso Tafur, Bashar M. Attar, Joseph A. Caprini, Yuchen Wang, Robert D. McBane, Waldemar E. Wysokiński, Irbaz Bin Riaz, Aaron S. Mansfield, Yiting Wang and Ana I. Casanegra and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Harry E Fuentes

44 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry E Fuentes United States 14 291 201 151 146 103 48 531
Shellie Josephs United States 14 60 0.2× 80 0.4× 335 2.2× 55 0.4× 35 0.3× 37 674
Stefanie Schüpke Germany 14 186 0.6× 615 3.1× 321 2.1× 21 0.1× 19 0.2× 40 788
Habeeb Majeed Canada 11 129 0.4× 104 0.5× 78 0.5× 138 0.9× 62 0.6× 20 459
Eric D. Tetzlaff United States 12 51 0.2× 48 0.2× 84 0.6× 127 0.9× 23 0.2× 37 401
Martin Thomas United Kingdom 13 398 1.4× 212 1.1× 386 2.6× 25 0.2× 82 0.8× 39 874
Prajwal Dhakal United States 14 68 0.2× 64 0.3× 75 0.5× 82 0.6× 9 0.1× 76 565
Francis Cajfinger France 9 519 1.8× 342 1.7× 138 0.9× 68 0.5× 227 2.2× 17 652
Ming Y. Lim United States 13 175 0.6× 109 0.5× 88 0.6× 29 0.2× 46 0.4× 86 663
Parveen Wasi Canada 14 201 0.7× 96 0.5× 84 0.6× 43 0.3× 214 2.1× 35 931
M. Monreal Spain 10 283 1.0× 200 1.0× 82 0.5× 118 0.8× 53 0.5× 27 452

Countries citing papers authored by Harry E Fuentes

Since Specialization
Citations

This map shows the geographic impact of Harry E Fuentes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry E Fuentes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry E Fuentes more than expected).

Fields of papers citing papers by Harry E Fuentes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry E Fuentes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry E Fuentes. The network helps show where Harry E Fuentes may publish in the future.

Co-authorship network of co-authors of Harry E Fuentes

This figure shows the co-authorship network connecting the top 25 collaborators of Harry E Fuentes. A scholar is included among the top collaborators of Harry E Fuentes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry E Fuentes. Harry E Fuentes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGarrah, Patrick W., et al.. (2024). Alpelisib and Immunotherapy: A Promising Combination for Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck. Cancer Reports. 7(10). e70023–e70023. 3 indexed citations
2.
3.
Riaz, Irbaz Bin, Harry E Fuentes, Yihong Deng, et al.. (2023). Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis. JAMA Network Open. 6(7). e2325283–e2325283. 21 indexed citations
4.
5.
Choong, Grace M., Elizabeth Cathcart-Rake, Narjust Florez, et al.. (2023). Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research Retreat. Journal of Cancer Education. 39(1). 58–64.
6.
Riaz, Irbaz Bin, Harry E Fuentes, Syed Arsalan Ahmed Naqvi, et al.. (2021). Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis. Mayo Clinic Proceedings. 97(2). 308–324. 14 indexed citations
7.
Fuentes, Harry E, et al.. (2019). Gaps of care in patients with venous thrombotic embolism: a qualitative study. International Angiology. 38(4). 284–290. 10 indexed citations
8.
Fuentes, Harry E, Alfonso Tafur, Joseph A. Caprini, et al.. (2019). Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE Database. International Angiology. 38(3). 173–184. 16 indexed citations
9.
Fuentes, Harry E, Robert D. McBane, Waldemar E. Wysokiński, et al.. (2019). Direct Oral Factor Xa Inhibitors for the Treatment of Acute Cancer-Associated Venous Thromboembolism: A Systematic Review and Network Meta-analysis. Mayo Clinic Proceedings. 94(12). 2444–2454. 28 indexed citations
10.
Fuentes, Harry E, et al.. (2019). Pancreatic cancer thromboembolic outcomes: rate of thrombosis after adenocarcinoma and non-adenocarcinoma pancreatic cancer surgery. International Angiology. 38(3). 194–200. 3 indexed citations
11.
12.
Fuentes, Harry E, et al.. (2018). Primary Liver Diffuse Large B-Cell Lymphoma following Complete Response for Hepatitis C Infection after Direct Antiviral Therapy. Acta Haematologica. 139(2). 77–80. 6 indexed citations
13.
Fugar, Setri, et al.. (2018). CARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE. Journal of the American College of Cardiology. 71(11). A1155–A1155. 9 indexed citations
14.
15.
Wang, Yuchen, Bashar M. Attar, Keiki Hinami, et al.. (2017). Characteristics and Impacts of Venous Thromboembolism in Patients with Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer. 49(3). 275–282. 15 indexed citations
16.
17.
Fuentes, Harry E, et al.. (2017). Predictors of active cancer thromboembolic outcomes: mortality associated with calf deep vein thrombosis. International Angiology. 36(6). 553–557. 10 indexed citations
18.
Fuentes, Harry E, et al.. (2017). Validation of a Patient-Completed Caprini Risk Score for Venous Thromboembolism Risk Assessment. SHILAP Revista de lepidopterología. 1(2). e106–e112. 32 indexed citations
19.
Wang, Yuchen, et al.. (2017). Evaluation of the prognostic value of platelet to lymphocyte ratio in patients with hepatocellular carcinoma. Journal of Gastrointestinal Oncology. 8(6). 1065–1071. 28 indexed citations
20.
Fuentes, Harry E, et al.. (2017). Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer. Thrombosis Research. 154. 28–34. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shellie Josephs Breakdown of academic impact, for papers by Stefanie Schüpke Breakdown of academic impact, for papers by Habeeb Majeed Breakdown of academic impact, for papers by Eric D. Tetzlaff Breakdown of academic impact, for papers by Martin Thomas Breakdown of academic impact, for papers by Prajwal Dhakal Breakdown of academic impact, for papers by Francis Cajfinger Breakdown of academic impact, for papers by Ming Y. Lim Breakdown of academic impact, for papers by Parveen Wasi Breakdown of academic impact, for papers by M. Monreal
Rankless by CCL
2026